Press Releases

Press Releases

November 18, 2020
Geist brings operational experience to Quanterix as the company scales to support rapid growth and commercial success
November 05, 2020
GAAP revenue including one-time License and Grant revenue $31.4M; Non-GAAP revenue $18.3M, an increase of 22% versus prior year
October 06, 2020
$18.2 million in Phase 2 funding will support the development and scale-up of COVID-19 antigen test based on Simoa® technology  
October 05, 2020
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exclusive royalty-bearing license agreement with Abbot

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more